ANS II Flashcards
parasympathetic effects can be mimicked by..
- muscarinic receptor agonists (carbachol, pilocarpine)
- acetylcholinesterase inhibitors (neostigmine)
parasympathetic effects can be blocked by..
- muscarinic receptor antagonists (atropine)
- skeletal neuromuscular junction blockers (D-tubocurarine)
parasympathomimetics
stimulates parasympathetic nervous system
therapeutic uses of parasympathomimetics
- reduce intraocular pressure in glaucoma; facilitate outlflow of aqueous (can cause cataracts with long term use)
- increase peristalsis of GI tract
- increase motility of urinary tracts
- increase salivary secretions
ACh released at the synapse acts for a few milliseconds before..
it is metabolized in the synapse
acetylcholinesterase (AChE)
metabolize ACh in the synaptic cleft on the outer membrane of the post junctional cell
two types of cholinesterase enzymes
- AChE
- butyrylcholinerterase (BuChE; aka plasma/pseudoChE)
BuChE
-located at non-neuronal sites; plasma and liver
Most enzyme inhibitors used clinically … discriminate between the two types of ChE
DO NOT
AChE inhibitors
increase duration of action of the released ACh at the synapse
3 types of chemical reaction that is produced by cholinesterase
- acetylation
- carbamylation
- phosphorylation
acetylation
introduce an acetyl group
-acetylated enzyme recovers rapidly
carbamylation
enzyme recovers more slowly, 3-4 hours
- reversible
- used therapeutically
phosphorylation
- poisons the enzyme
- irreversible
- 6 hours
catalytic region of cholinesterase enzyme
ser-OH
neostigmine
a reversible AChE inhibitor that causes carbamylation
diisopropyl flurophosphate
an irreversible AChE inhibitor that causes phorphorylation
2-PAM
an oxide that if administered before aging occurs, can bind to and release a phosphate moiety attached to the enzyme during phosphorylation; reversing the enzyme inhibition
donepezil and tacrine (also rivastigmine and galantamine)
ChE inhibitors in the CNS that have higher affinity and partition into lipids and cross the blood/brain barrier
ChE inhibitors in the intestine
relax sphincters to facilitate peristaltic movement (in postoperative ileum, congenital megacolon)
ChE inhibitors in the bladder
treat urinary retention due to atony of smooth muscle
ChE inhibitors in the skeletal muscle neuromuscular junction
LOW doses used to treat patients with myasthenia gravis, who have weakness of skeletal muscles
-also used to diagnose it
intermediate doses and high doses ChE inhibitors in skeletal muscle neuromuscular junction
i: fasciculations and fibrillations
h: persistent depolarization and muscle paralysis
anti-ChE agents
reverse antagonisms by competitive neuromuscular blockers but add to the depolarization and paralysis by succinylcholine and make it worse